000950 重药控股
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.3562.5115.7139.30310.778
总资产报酬率 ROA (%)0.5720.4351.0351.7822.183
投入资产回报率 ROIC (%)0.9600.7381.7102.7953.409

边际利润分析
销售毛利率 (%)7.2157.4347.9938.5819.178
营业利润率 (%)1.0690.6981.2312.1162.497
息税前利润/营业总收入 (%)1.9542.0382.8933.7844.267
净利润/营业总收入 (%)0.8560.4990.9321.7152.064

收益指标分析
经营活动净收益/利润总额(%)166.550129.526108.17482.89486.852
价值变动净收益/利润总额(%)21.16373.42232.87820.07927.183
营业外收支净额/利润总额(%)-1.176-0.9210.1502.5451.225

偿债能力分析
流动比率 (X)1.2331.3031.2721.1981.303
速动比率 (X)1.0191.0771.0721.0041.112
资产负债率 (%)75.67075.29175.63877.77676.325
带息债务/全部投入资本 (%)68.70969.68966.94969.01066.250
股东权益/带息债务 (%)42.36240.36146.04442.10647.097
股东权益/负债合计 (%)22.55422.57923.35823.94625.890
利息保障倍数 (X)2.1781.5141.7422.3462.453

营运能力分析
应收账款周转天数 (天)153.927145.517139.277144.535137.356
存货周转天数 (天)47.10544.84841.08940.38837.100